The FOP metamorphogene encodes a novel type I receptor that dysregulates BMP signaling
Authors:
- Frederick S. KaplanFrederick S. Kaplan
- Robert J. PignoloRPRobert J. Pignolo
- Eileen M. ShoreESEileen M. Shore
- 1 October 2009
- journal article
- review article
- Published by Elsevier in Cytokine & Growth Factor Reviews
- Vol. 20 (5-6) , 399-407
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- Circulating Osteogenic Precursor Cells in Heterotopic Bone FormationStem Cells, 2009
- When one skeleton is enough: approaches and strategies for the treatment of fibrodysplasia ossificans progressiva (FOP)Drug Discovery Today: Therapeutic Strategies, 2009
- Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1Human Mutation, 2008
- BMP type I receptor inhibition reduces heterotopic ossificationNature Medicine, 2008
- Skeletal metamorphosis in fibrodysplasia ossificans progressiva (FOP)Journal of Bone and Mineral Metabolism, 2008
- Structure–activity relationship study of bone morphogenetic protein (BMP) signaling inhibitorsBioorganic & Medicinal Chemistry Letters, 2008
- Fibrodysplasia ossificans progressivaBest Practice & Research Clinical Rheumatology, 2008
- Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolismNature Chemical Biology, 2007
- Integrating Patterning Signals: Wnt/GSK3 Regulates the Duration of the BMP/Smad1 SignalCell, 2007
- The TGFβ Receptor Activation ProcessMolecular Cell, 2001